Testosterone Therapy Frequently Prescribed Without Recommended Diagnostic Workup
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
Research suggests that only 12% of men receiving testosterone prescriptions underwent appropriate testing.
The study will analyze three key proteins to determine if blood-based biomarkers can provide an earlier and more accessible diagnostic method.
The qPCR-based test detects variants that increase risk of severe fluoropyrimidine chemotherapy toxicity.
Revvity, Inc. has launched the IDS i20, a fully automated, high-throughput platform for ChLIA, enabling labs to consolidate specialty tests.
The Guardant Hereditary Cancer test is a blood-based genetic screening tool that identifies inherited cancer risk variants.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...